Pulmonary tuberculosis: Virulence of Mycobacterium africanum and relevance in HIV co-infection

Tuberculosis

Volumn 88, Issue 5, 2008, Pages 482-489

  Meyer, Christian G ^a   Scarisbrick, Genevieve ^b   Niemann, Stefan ^c   Browne, Edmund N L ^d   Chinbuah, Margaret Amanua ^e   Gyapong, John ^e   Osei, Ivy ^e   Owusu Dabo, Ellis ^d,f   Kubica, Tanja ^c   Rüsch Gerdes, Sabine ^c   Thye, Thorsten ^a,g   Horstmann, Rolf D ^a  

^a BERNHARD NOCHT INSTITUTE FOR TROPICAL MEDICINE   (Germany)

^b KOMFO ANOKYE TEACHING HOSPITAL   (Ghana)

^c RESEARCH CENTER BORSTEL   (Germany)

^d KWAME NKRUMAH UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Ghana)

^e Health Research Unit Ghana Health Service   (Ghana)

^f KUMASI CENTRE FOR COLLABORATIVE RESEARCH IN TROPICAL MEDICINE   (Ghana)

^g UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

M. africanum; Opportunist; Tuberculosis; Virulence

Indexed keywords

ADULT; AFRICA; ANTIBIOTIC RESISTANCE; ARTICLE; COMPARATIVE STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MYCOBACTERIUM AFRICANUM; MYCOBACTERIUM TUBERCULOSIS; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; SELF REPORT; THORAX RADIOGRAPHY;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; FEMALE; GHANA; HIV INFECTIONS; HUMANS; MALE; MYCOBACTERIUM; RADIOGRAPHY, THORACIC; SPUTUM; TUBERCULOSIS, MULTIDRUG-RESISTANT; TUBERCULOSIS, PULMONARY; VIRULENCE;

EID: 49349099266     PISSN: 14729792     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tube.2008.05.004     Document Type: Article

References (25)

1. Touré I.M. The situation with regard to Mycobacterium africanum in West Africa. Bull Int Union Tuberc 57 (1982) 234-241
2. Huet M., Rist N., Boube G., et al. Bacteriological study of tuberculosis in Cameroon. Rev Tuberc Pneumol (Paris) 35 (1971) 413-426
3. Niemann S., Rusch-Gerdes S., Joloba M.L., Whalen C.C., Guwatudde D., Ellner J.J., et al. Mycobacterium africanum subtype II is associated with two distinct genotypes and is a major cause of human tuberculosis in Kampala, Uganda. J Clin Microbiol 40 (2002) 3398-3405
4. Gagneux S., and Small P.M. Global phylogeography of Mycobacterium tuberculosis and implications for tuberculosis product development. Lancet Infect Dis 7 (2007) 328-337
5. de Jong B.C., Hill P.C., Aiken A., Jeffries D.J., Onipede A., Small P.M., et al. Clinical presentation and outcome of tuberculosis patients infected by M. africanum versus M. tuberculosis. Int J Tuberc Lung Dis 11 (2007) 450-456
6. de Jong B.C., Hill P.C., Brookes R.H., Otu J.K., Peterson K.L., Small P.M., et al. Mycobacterium africanum: a new opportunistic pathogen in HIV infection?. AIDS 19 (2005) 1714-1715
7. Kamerbeek J., Schouls L., Kolk A., van Agterveld M., van Soolingen D., Kuijper S., et al. Simultaneous detection and strain differentiation of Mycobacterium tuberculosis for diagnosis and epidemiology. J Clin Microbiol 35 (1997) 907-914
8. van Embden J.D., Cave M.D., Crawford J.T., Dale J.W., Eisenach K.D., Gicquel B., et al. Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: recommendations for a standardized methodology. J Clin Microbiol 31 (1993) 406-409
9. Niemann S., Kubica T., Bange F.C., Adjei O., Browne E.N., Chinbuah M.A., et al. The species Mycobacterium africanum in the light of new molecular markers. J Clin Microbiol 42 (2004) 3958-3962
10. Murray M., and Alland D. Methodological problems in the molecular epidemiology of tuberculosis. Am J Epidemiol 155 (2002) 565-571
11. Lienhardt C., Fielding K., Sillah J.S., Bah B., Gustafson P., Warndorff D., et al. Investigation of the risk factors for tuberculosis: a case-control study in three countries in West Africa. Int J Epidemiol 34 (2005) 914-923
12. Hill P.C., Jackson-Sillah D., Donkor S.A., Otu J., Adegbola R.A., and Lienhardt C. Risk factors for pulmonary tuberculosis: a clinic-based case control study in The Gambia. BMC Public Health 6 (2006) 156
13. Jimenez-Corona M.E., Garcia-Garcia L., and DeRiemer K. Gender differentials of pulmonary tuberculosis transmission and reactivation in an endemic area. Thorax 61 (2006) 348-353
14. Tshibwabwa-Tumba E., Mwinga A., Pobee J.O., and Zumla A. Radiological features of pulmonary tuberculosis in 963 HIV-infected adults at three Central African Hospitals. Clin Radiol 52 (1997) 837-841
15. Lawn S.D., Evans A.J., Sedgwick P.M., and Acheampong J.W. Pulmonary tuberculosis: radiological features in West Africans coinfected with HIV. Br J Radiol 72 (1999) 339-344
16. Geng E., Kreiswirth B., Burzynski J., and Schluger N.W. Clinical and radiographic correlates of primary and reactivation tuberculosis: a molecular epidemiology study. JAMA 293 (2005) 2740-2745
17. Owusu-Dabo E., Adjei O., Meyer C.G., Horstmann R.D., Enimil A., Kruppa T.F., et al. Mycobacterium tuberculosis drug resistance, Ghana. Emerg Infect Dis 12 (2006) 1171-1172
18. Getahun H., Harrington M., O'Brien R., and Nunn P. Diagnosis of smear-negative pulmonary tuberculosis in people with HIV infection or AIDS in resource-constrained settings: informing urgent policy changes. Lancet 369 (2007) 2042-2049
19. Pitchenik A.E., and Rubinson H.A. The radiographic appearance of tuberculosis in patients with the acquired immune deficiency syndrome (AIDS) and pre-AIDS. Am Rev Respir Dis 131 (1985) 393-396
20. Long R., Maycher B., Scalcini M., and Manfreda J. The chest roentgenogram in pulmonary tuberculosis patients seropositive for human immunodeficiency virus type 1. Chest 99 (1991) 123-127
21. Batungwanayo J., Taelman H., Dhote R., Bogaerts J., Allen S., and Van de Perre P. Pulmonary tuberculosis in Kigali, Rwanda. Impact of human immunodeficiency virus infection on clinical and radiographic presentation. Am Rev Respir Dis 146 (1992) 53-56
22. HIV Sentinel Survey Report. Ghana AIDS Commission. http://www.ghanaids.gov.gh/gac/index.php (accessed November 1, 2007).
23. Corbett E.L., Marston B., Churchyard G.J., and De Cock K.M. Tuberculosis in sub-Saharan Africa: opportunities, challenges, and change in the era of antiretroviral treatment. Lancet 367 (2006) 926-937
24. World Health Organization. Global tuberculosis control: surveillance, planning, financing. WHO report 2005. WHO/HTM/TB/2005.349 (2005), World Health Organization, Geneva
25. Godreuil S., Torrea G., Terru D., Chevenet F., Diagbouga S., and Supply P. First molecular epidemiology study of Mycobacterium tuberculosis in Burkina Faso. J Clin Microbiol 45 (2007) 921-927